Answers are grounded in this paper and cite their sources.
Mycobacterium tuberculosis cystathionine beta‐synthase ( Mtb CBS), a pyridoxal‐5′‐phosphate (PLP)‐dependent enzyme, regulates sulfur metabolism and redox homeostasis, making it a model enzyme for inhibition studies and to understand scaffold behavior. Amino acids remains as an attractive scaffold for designing novel inhibitors having reduced cytotoxicity and improved properties for cellular uptake. This study integrates computational, biophysical, and structural approaches to provide for a potential scaffold that could be further modified to inhibit Mtb CBS. Structure‐based sequence alignment of CBS homologs identified seven conserved polar/charged regions critical for PLP‐substrate interactions. Molecular docking of polar substrate analogs (threonine, histidine, glutamic acid, and arginine) at the conserved active site revealed distinct binding modes for histidine, glutamic acid, and arginine. Molecular dynamics simulations demonstrated persistent binding of histidine, stabilized by hydrophobic interactions relative to other analogs. Experimental studies revealed histidine’s ability to form stable external aldimine adducts, modulating enzyme thermostability (Δ T m ), akin to known reacting substrates. Finally, cryo‐EM‐based structural studies revealed two classes of Mtb CBS, one with extra density suggesting the noncovalently bound histidine and the unbound WT Mtb CBS maintaining internal aldimine. This suggests that exploration of the chemical modification space of the histidine moiety might provide us with a potential inhibitor against Mtb CBS and enzymes of the RTS pathway.
No takes yet. Share an insight, caveat, or question.
Polepalli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: